Development of the alopecia areata scale for clinical use: Results of an academic–industry collaborative effortBrett King, Maryanne M. Senna, Natasha Atanaskova Mesinkovska et al.|Journal of the American Academy of Dermatology|2021Cited by 79
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)Brett King, James V. Cassella, Matthew Zirwas et al.|Journal of the American Academy of Dermatology|2024Cited by 79